Indication

Guillain-Barré Syndrome

Aliases

Overall objective response rate (oORR)

1 clinical trial

1 product

Clinical trial

An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients

Status: Completed, Estimated PCD: 2024-02-27

Product